UNSPSC 51282104: Carumonam

This classification denotes a beta-lactam antibiotic with the molecular formula C12H14N6O10S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 486890PI06 chemically known as acetic acid, (((2-((2-(((aminocarbonyl)oxy)methyl)-4-oxo-1-sulfo-3-azetidinyl)amino)-1-(2-amino-4-thiazolyl)-2-oxoethylidene)amino)oxy)-, (2s-(2.alpha.,3.alpha.(z)))- but generally known as carumonam, which bears US NIH Compound Identifier 9576417.

UNSPSC 51282104 Carumonam is a Commodity code under which state and local governments procure pharmaceutical products, specifically antibiotics and emergency medical supplies. Recent activity shows state health departments and county public health agencies sourcing individual drug products through both piggyback cooperative purchasing vehicles and direct competitive bidding. The Illinois Department of Public Health leveraged the MMCAP Infuse consortium to procure Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets via a piggyback award to Chartwell Rx LLC, while Seminole County, Florida solicited Naloxone and Safe Drug Deactivation Systems through direct IFB. Both procurements serve public health and emergency response missions, with state health departments and county health authorities as the primary issuing bodies under this code.

The Illinois and Florida procurements represent the recent geographic activity on record. The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback contract in August 2026 to supply antibiotic tablets for state health emergency preparedness. Seminole County, Florida posted an IFB (26IFB60459723LAS) on June 30, 2026 for annual delivery of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems to the Seminole County Community Health Building in Sanford, with quarterly deliveries and a two-year initial term plus one-year renewal option. Both procurements require vendors to manage logistics, including shipping and delivery to specified locations, and impose compliance requirements such as drug-free workplace certification and E-Verify eligibility verification.